Vimarsana
Biggest News Aggregation in the World

Reference Member State News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Reference Member State. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Reference Member State Today - Breaking & Trending Today

Pyros Pharmaceuticals Announces Positive Outcome of the European Decentralised Procedure for Approva - Vimarsana News

Pyros Pharmaceuticals Announces Positive Outcome of the European Decentralised Procedure for Approva

PARSIPPANY, N.J.--(BUSINESS WIRE)--Pyros Pharmaceuticals, Inc. (Pyros or the Company), a leader in the development of enhanced specialty pharmaceuticals for rare diseases, announced today the positive outcome of the Decentralised Procedure (DCP) for VIGZIP™ (vigabatrin oral solution) in Europe. This significant mile...

Ipsen : delivers encouraging sales growth in the first quarter of 2021 despite the pandemic, and confirms its full-year guidance - Vimarsana News

Ipsen : delivers encouraging sales growth in the first quarter of 2021 despite the pandemic, and confirms its full-year guidance

Paris , 22 April 2021 - Ipsen , a global specialty-driven biopharmaceutical group, publishes its sales performance for the first quarter of 2021: Q1 2021 sales summary ... | June 16, 2023

Telix Reports Second Quarter 2022 Financial Results - Vimarsana News

Telix Reports Second Quarter 2022 Financial Results

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
In review: the life sciences regulatory regime in Malta - Vimarsana News

In review: the life sciences regulatory regime in Malta

This article reviews the essential regulatory considerations surrounding medicines and medical devices in Malta, including clinical trials and marketing authorisations.

In review: the life sciences regulatory regime in Italy - Vimarsana News

In review: the life sciences regulatory regime in Italy

This article reviews the essential regulatory considerations surrounding medicines and medical devices in Italy, including clinical trials and marketing authorisations.